PortfoliosLab logoPortfoliosLab logo
JBIO vs. BTI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

JBIO vs. BTI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Jade Biosciences, Inc (JBIO) and British American Tobacco p.l.c. (BTI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, JBIO achieves a 28.00% return, which is significantly higher than BTI's 10.19% return.


JBIO

1D
-1.25%
1M
-8.18%
6M
26.52%
YTD
28.00%
1Y
186.65%
3Y*
124.22%
5Y*
71.21%
10Y*
ALL TIME*
45.59%

BTI

1D
-1.69%
1M
-0.45%
6M
2.81%
YTD
10.19%
1Y
18.00%
3Y*
31.65%
5Y*
18.80%
10Y*
6.46%
ALL TIME*
17.68%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$243.05M$251.57M$264.36M
$14.42M$18.92M$20.53M

JBIO vs. BTI - Yearly Performance Comparison


2026 (YTD)20252024202320222021
JBIO
Jade Biosciences, Inc
28.00%5,473.10%-88.29%-22.76%148.52%-57.89%
BTI
British American Tobacco p.l.c.
10.19%65.81%35.44%-19.97%14.91%0.60%

Correlation

The correlation between JBIO and BTI is 0.03, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.03

Correlation (3Y)
Balances recent behavior with more history.

0.08

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.07

Correlation (All Time)
Calculated using the full available price history since Jun 30, 2021

0.07

Fundamentals

Market Cap

JBIO:

$644.36M

BTI:

$131.19B

EPS

JBIO:

-$2.65

BTI:

£4.94

Total Revenue (TTM)

JBIO:

$0.00

BTI:

£51.48B

Gross Profit (TTM)

JBIO:

-$9.00K

BTI:

£42.82B

EBITDA (TTM)

JBIO:

-$133.57M

BTI:

£20.34B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

JBIO vs. BTI — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

JBIO
JBIO Risk / Return Rank: 9292
Overall Rank
JBIO Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
JBIO Sortino Ratio Rank: 9191
Sortino Ratio Rank
JBIO Omega Ratio Rank: 8888
Omega Ratio Rank
JBIO Calmar Ratio Rank: 9292
Calmar Ratio Rank
JBIO Martin Ratio Rank: 9393
Martin Ratio Rank

BTI
BTI Risk / Return Rank: 6969
Overall Rank
BTI Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
BTI Sortino Ratio Rank: 6666
Sortino Ratio Rank
BTI Omega Ratio Rank: 6363
Omega Ratio Rank
BTI Calmar Ratio Rank: 7373
Calmar Ratio Rank
BTI Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

JBIO vs. BTI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Jade Biosciences, Inc (JBIO) and British American Tobacco p.l.c. (BTI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


JBIOBTIDifference
Sharpe ratioReturn per unit of total volatility

+1.54

Sortino ratioReturn per unit of downside risk

+1.54

Omega ratioGain probability vs. loss probability

1.34

1.15

+0.19

Calmar ratioReturn relative to maximum drawdown

3.98

1.42

+2.55

Martin ratioReturn relative to average drawdown

11.49

2.90

+8.60

JBIO vs. BTI - Sharpe Ratio Comparison

The current JBIO Sharpe Ratio is 2.33, which is higher than the BTI Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of JBIO and BTI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

JBIO vs. BTI - Drawdown Comparison

The maximum JBIO drawdown since its inception was -95.41%, which is greater than BTI's maximum drawdown of -64.11%. Use the drawdown chart below to compare losses from any high point for JBIO and BTI.


Loading charts...

Drawdown Indicators


JBIOBTIDifference

Max Drawdown

Largest peak-to-trough decline

-95.41%

-64.11%

-31.30%

Max Drawdown (1Y)

Largest decline over 1 year

-44.21%

-13.75%

-30.46%

Max Drawdown (3Y)

Largest decline over 3 years

-95.41%

-13.75%

-81.66%

Max Drawdown (5Y)

Largest decline over 5 years

-95.41%

-29.94%

-65.47%

Max Drawdown (10Y)

Largest decline over 10 years

-56.00%

Current Drawdown

Current decline from peak

-26.44%

-7.81%

-18.63%

Average Drawdown

Average peak-to-trough decline

-44.62%

-12.92%

-31.70%

Ulcer Index

Depth and duration of drawdowns from previous peaks

15.27%

6.74%

+8.53%

Volatility

JBIO vs. BTI - Volatility Comparison

Jade Biosciences, Inc (JBIO) has a higher volatility of 15.16% compared to British American Tobacco p.l.c. (BTI) at 10.28%. This indicates that JBIO's price experiences larger fluctuations and is considered to be riskier than BTI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


JBIOBTIDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.16%

10.28%

+4.88%

Volatility (6M)

Calculated over the trailing 6-month period

54.20%

20.33%

+33.87%

Volatility (1Y)

Calculated over the trailing 1-year period

75.63%

24.73%

+50.90%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

1,580.65%

21.62%

+1,559.03%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

1,567.07%

24.29%

+1,542.78%

Dividends

JBIO vs. BTI - Dividend Comparison

JBIO has not paid dividends to shareholders, while BTI's dividend yield for the trailing twelve months is around 5.22%.


PositionTTM20252024202320222021202020192018201720162015
BTI
British American Tobacco p.l.c.
5.22%5.29%8.18%9.72%7.23%7.98%7.22%6.35%8.53%4.27%3.85%4.11%
JBIO
Jade Biosciences, Inc
0.00%15.55%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

JBIO vs. BTI - Financials Comparison

This section allows you to compare key financial metrics between Jade Biosciences, Inc and British American Tobacco p.l.c.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


JBIO and BTI have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

JBIO has higher volatility (15.16%) compared to BTI (10.28%). In terms of maximum drawdown, JBIO dropped -95.41% vs BTI's -64.11%.

JBIO currently has the higher Sharpe Ratio (2.33 vs 0.79), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for JBIO and BTI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer